Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Afghan Black Cumin (Nigella sativa) seeds contain thymoquinone as the primary bioactive compound, demonstrating potent antioxidant and anti-inflammatory effects through Nrf2 and NF-κB pathway modulation. The seeds exhibit cytotoxic properties against cancer cells with LC50 values of 2.720 ± 0.2 mg/ml in breast cancer cell lines.
Reported Benefits (Provisional)
Origin & History
Afghan Black Cumin (Nigella sativa) is a flowering plant native to the mountainous regions of Afghanistan, thriving in dry, well-drained soils with a temperate, semi-arid climate. Its seeds are highly valued in traditional medicine and functional nutrition for their rich bioactive compounds, particularly thymoquinone.
Research Narrative (Provisional)
Scientific studies highlight the immune-boosting, digestive, and anti-inflammatory properties of Afghan Black Cumin. Research specifically demonstrates thymoquinone's role in enhancing immune health, improving digestion, and reducing chronic inflammation. Further clinical trials are exploring its broad spectrum of therapeutic applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Thymoquinone (a potent antioxidant and anti-inflammatory compound). - Vitamins: B1 (thiamine), B2 (riboflavin), folate. - Minerals: Calcium, iron, zinc.
Reported Mechanism (Provisional)
Thymoquinone upregulates antioxidant enzymes SOD and catalase while inhibiting pro-inflammatory cytokines TNF-α, IL-6, and IL-1β through IRAK-linked AP-1/NF-κB pathways. The compound modulates cellular metabolism via AMPK regulation and triggers cancer cell apoptosis by disrupting PI3K/AKT signaling and upregulating phosphatase and tensin homolog. Additional bioactive compounds including flavonoids, triterpenoids, and alkaloids provide synergistic therapeutic effects.
Clinical Narrative (Provisional)
Current research on Afghan Black Cumin focuses primarily on in vitro studies rather than comprehensive human clinical trials. Laboratory studies demonstrate cytotoxic effects against MCF-7 breast cancer cells with quantified LC50 values, while preclinical research supports immune-boosting and digestive benefits. Clinical evidence remains limited with ongoing trials exploring therapeutic applications, though specific sample sizes and quantified human outcomes are not well-documented in available literature. The evidence base requires expansion through controlled human studies to establish definitive clinical efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.